Levocetirizine Arrow (Levocetirizine Dihydrochloride)

Levocetirizine acts as a selective peripheral H1‑receptor antagonist. By blocking histamine binding at these receptors, it prevents the cascade that leads to vasodilation, increased vascular permeability, and bronchial smooth‑muscle contraction, thereby alleviating typical allergic symptoms.

The prescribed dose of Levocetirizine Arrow is determined by a qualified healthcare professional based on the patient’s age, condition severity, and renal function. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Levocetirizine during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before starting therapy.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levocetirizine is the active enantiomer of cetirizine, offering similar efficacy with a lower incidence of sedation for many patients. Compared with first‑generation antihistamines, it provides effective allergy relief while crossing the blood‑brain barrier to a lesser extent, reducing central side effects.

Store Levocetirizine Arrow at ambient temperature, preferably below 25 °C. Keep the tablets in the original blister pack or container, protect them from moisture, heat and direct sunlight to maintain potency throughout the shelf life.

Levocetirizine Arrow is taken orally, usually with a glass of water. It can be taken with or without food, according to the prescriber’s guidance. Swallow the tablet whole; do not crush or chew unless specifically instructed.

Serious adverse reactions, although rare, include anaphylaxis, Stevens‑Johnson syndrome, angioedema, and significant hepatic dysfunction. Patients should seek immediate medical attention if they experience symptoms such as swelling of the face or throat, rash with blisters, or signs of liver injury.

Levocetirizine Arrow should be avoided in individuals with known hypersensitivity to levocetirizine or any component of the formulation. Caution is also advised for patients with severe renal impairment, as dose adjustment may be required, and for those taking interacting medications listed under major interactions.